您当前的位置：

Eleclazine hydrochloride

目录号: PL09987 纯度: ≥99%

Eleclazine (GS 6615) hydrochloride 是一种具有选择性的心脏晚期钠电流 (sodium current) 抑制剂和钾电流 (potassium current) 的弱抑制剂，IC50 值分别为 <1 μM 和约 14.2 μM。在猪模型中，Eleclazine hydrochloride 对自发性心房早搏、复极交替和异质性以及心房纤颤同时具有保护作用。Eleclazine hydrochloride 可用于心律失常的研究。

CAS No. :1448754-43-5

商品编号	规格	价格	会员价
PL09987-5mg	5mg	¥1175.00	请登录
PL09987-10mg	10mg	¥1775.00	请登录
PL09987-50mg	50mg	¥4175.00	请登录
PL09987-100mg	100mg	¥5625.00	请登录
PL09987-200mg	200mg	¥7585.00	请登录
PL09987-10mM*1mLinDMSO	10mM*1mLinDMSO	¥5304.00	请登录
PL09987-1 mL x 10 mM (in DMSO)		¥1185.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!

加入购物车在线咨询收藏产品大包装询价

中文名称	Eleclazine hydrochloride
中文别名	Eleclazine (hydrochloride)
英文名称	Eleclazine hydrochloride
英文别名	Eleclazine (hydrochloride);GS 6615 hydrochloride;GS-6615 hydrochloride;Eleclazine hydrochloride;Eleclazine HCl;4R1JP3Q4HI;4-(Pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one hydrochloride;1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-(4-(trifluoromethoxy)phenyl)-, hydrochloride (1:1);1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-, hydrochloride (1:1);BCP32600
Cas No.	1448754-43-5
分子式	C₂₁H₁₇ClF₃N₃O₃
分子量	451.83
包装储存	4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
详情描述	Eleclazine (GS 6615) hydrochloride 是一种具有选择性的心脏晚期钠电流 (sodium current) 抑制剂和钾电流 (potassium current) 的弱抑制剂，IC50 值分别为 <1 μM 和约 14.2 μM。在猪模型中，Eleclazine hydrochloride 对自发性心房早搏、复极交替和异质性以及心房纤颤同时具有保护作用。Eleclazine hydrochloride 可用于心律失常的研究。

产品详情

Eleclazine (GS 6615) hydrochloride 是一种具有选择性的心脏晚期钠电流 (sodium current) 抑制剂和钾电流 (potassium current) 的弱抑制剂，IC₅₀ 值分别为 <1 μM 和约 14.2 μM。在猪模型中，Eleclazine hydrochloride 对自发性心房早搏、复极交替和异质性以及心房纤颤同时具有保护作用。Eleclazine hydrochloride 可用于心律失常的研究。

生物活性

Eleclazine (GS 6615) hydrochloride is a selective cardiac late sodium current inhibitor and a weak inhibitor of potassium current with IC 50 value of <1 μM and approximately 14.2 μM, respectively. Eleclazine hydrochloride shows concurrent protection against autonomically induced atrial premature beats, repolarization alternans and heterogeneity, and atrial fibrillation in porcine model. Eleclazine hydrochloride can be used to research cardiac arrhythmias.

性状

Solid

IC50 & Target[1][2]

Sodium current, Potassium current

体外研究(In Vitro)

Eleclazine inhibits sodium current in hiPSC-derived cardiomyocytes with an IC50 of 2.5 μM. has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究(In Vivo)

Eleclazine (0.3 and 0.9 mg/kg; IV; infused over 15 minutes) reduces the incidence of epinephrine-induced ventricular premature beats and couplets, and shortens ventricular QT and atrial PTa intervals. has not independently confirmed the accuracy of these methods. They are for reference only. Animal Model:

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

ClinicalTrial

参考文献

[1]. Bacic D, et al. Eleclazine, an inhibitor of the cardiac late sodium current, is superior to flecainide in suppressing catecholamine-induced ventricular tachycardia and T-wave alternans in an intact porcine model. Heart Rhythm. 2017 Mar;14(3):448-454.
[2]. Rajamani S et al. The novel late Na+ current inhibitor, GS-6615 (eleclazine) and its anti-arrhythmic effects in rabbit isolated heart preparations. Br J Pharmacol. 2016 Jul 23.

溶解度数据	In Vitro: DMSO : 50 mg/mL (110.66 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

Eleclazine hydrochloride

相关产品

The molarity calculator equation

The dilution calculator equation